Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

Mara Silva(Instituto Português de Oncologia Francisco Gentil), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil)

BMC Medicine

May 14, 2010

10.1186/1741-7015-8-26

Cited by 22

Related Papers

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

|European Urology|2014|250

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

|European Urology|2019|239

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

|The Lancet Oncology|2021|93